231 related articles for article (PubMed ID: 21819332)
21. Drug targets for lymphatic filariasis: a bioinformatics approach.
Sharma OP; Vadlamudi Y; Kota AG; Sinha VK; Kumar MS
J Vector Borne Dis; 2013 Sep; 50(3):155-62. PubMed ID: 24220073
[TBL] [Abstract][Full Text] [Related]
22. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.
Debrah AY; Mand S; Specht S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Larbi J; Lawson B; Taylor M; Adjei O; Hoerauf A
PLoS Pathog; 2006 Sep; 2(9):e92. PubMed ID: 17044733
[TBL] [Abstract][Full Text] [Related]
23. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
24. Some morphological aspects of Wuchereria bancrofti uterus after treatment with diethylcarbamazine.
Peixoto CA
Micron; 2005; 36(1):17-22. PubMed ID: 15582474
[TBL] [Abstract][Full Text] [Related]
25. New insights into the biology of filarial infections.
Specht S; Wanji S
J Helminthol; 2009 Jun; 83(2):199-202. PubMed ID: 19379544
[TBL] [Abstract][Full Text] [Related]
26. Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
Sjoberg HT; Pionnier N; Aljayyoussi G; Metuge HM; Njouendou AJ; Chunda VC; Fombad FF; Tayong DB; Gandjui NVT; Akumtoh DN; Chounna PWN; Ndzeshang BL; Lachaud S; Tekle F; Quirynen L; Engelen M; Baeten B; Steven A; Ward SA; Taylor MJ; Wanji S; Turner JD
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006356. PubMed ID: 30650071
[TBL] [Abstract][Full Text] [Related]
27. Designing antifilarial drug trials using clinical trial simulators.
Walker M; Hamley JID; Milton P; Monnot F; Pedrique B; Basáñez MG
Nat Commun; 2020 Jun; 11(1):2685. PubMed ID: 32483209
[TBL] [Abstract][Full Text] [Related]
28. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
29. The microfilaricidal activity of ivermectin in vitro and in vivo.
Devaney E; Howells RE
Tropenmed Parasitol; 1984 Mar; 35(1):47-49. PubMed ID: 6546818
[TBL] [Abstract][Full Text] [Related]
30. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.
Hoerauf A; Specht S; Büttner M; Pfarr K; Mand S; Fimmers R; Marfo-Debrekyei Y; Konadu P; Debrah AY; Bandi C; Brattig N; Albers A; Larbi J; Batsa L; Taylor MJ; Adjei O; Büttner DW
Med Microbiol Immunol; 2008 Sep; 197(3):295-311. PubMed ID: 17999080
[TBL] [Abstract][Full Text] [Related]
31. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
[TBL] [Abstract][Full Text] [Related]
32. Experimental infection of humans with filariae.
Nutman TB
Rev Infect Dis; 1991; 13(5):1018-22. PubMed ID: 1962076
[TBL] [Abstract][Full Text] [Related]
33. Macrocyclic lactones and Dirofilaria immitis microfilariae.
Bowman DD; Mannella C
Top Companion Anim Med; 2011 Nov; 26(4):160-72. PubMed ID: 22152603
[TBL] [Abstract][Full Text] [Related]
34. Metrifonate in onchocerciasis and lymphatic filariasis.
Abaru DE; McMahon JE
Tropenmed Parasitol; 1978 Jun; 29(2):175-7. PubMed ID: 675839
[TBL] [Abstract][Full Text] [Related]
35. Antifilarials and their mode of action.
Subrahmanyam D
Ciba Found Symp; 1987; 127():246-64. PubMed ID: 3297557
[TBL] [Abstract][Full Text] [Related]
36. Effect of CGP 20376 on Brugia malayi and parasite antigenemia in jirds.
Chandrashekar R; Subrahmanyam D; Weil GJ
J Parasitol; 1991 Jun; 77(3):479-82. PubMed ID: 2040959
[TBL] [Abstract][Full Text] [Related]
37. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
38. Discovery of potent inhibitors targeting Glutathione S-transferase of Wuchereria bancrofti: a step toward the development of effective anti-filariasis drugs.
Sureshan M; Prabhu D; Rajamanikandan S; Saraboji K
Mol Divers; 2024 Apr; 28(2):765-785. PubMed ID: 36797509
[TBL] [Abstract][Full Text] [Related]
39. New strategies to combat filariasis.
Hoerauf A
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):211-22. PubMed ID: 16597203
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the chemotherapy of lymphatic filariasis.
Navaratnam V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
